Driving with Parkinson s Disease Gina C. Pervall, MD

Similar documents
Parkinson s Disease and Driving

Objectives. The Problem. The Problem. The Problem. Assessing the Older Driver

Onanong Jitkritsadakul 1 and Roongroj Bhidayasiri 1,2*

MEDICAL FITNESS TO DRIVE EVALUATIONS

DMV Medical Programs: Best Practices and Proven Successes

The Road Map. Collisions and aging Function, skill and driving Licensing and assessment The future

DRIVING AT NIGHT. It s More Dangerous

The road to safety starts with us. DRIVING REHABILITATION

VA Medical Review of Drivers. Jackie Branche, MBA, RN Medical Compliance Officer Virginia DMV

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

Identifying Medically At-Risk Drivers

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Driving at Night. It's More Dangerous

Driving Cessation and HD

Issues for Patient Discussion

Prior Authorization with Quantity Limit Program Summary

MUSCULOSKELETAL AND NEUROLOGICAL DISORDERS

Driving Under the Influence - of Allergy Medicine

PARKINSON S AND RETIRING FROM DRIVING

Lori Grismore, OTR/L, Occupational Therapist USF Health Byrd Alzheimer s Center and Research Institute

Optimizing Clinical Communication in Parkinson s Disease:

Subject: The Case for a Provincial 0.00% BAC Limit for All Drivers Under the Age of 21

Mature Driver Safety. Rich Kirkpatrick Driver Safety Manager Bureau of Driver Licensing PennDOT

The role of memory on patients with mild cognitive impairment. Sophia Vardaki, PhD National Technical University of Athens

Safe Mobility at Any Age Identifiers of High-Risk Drivers: An Occupational Therapy Perspective

III./3.1. Movement disorders with akinetic rigid symptoms

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Chapter 7 Guided Notes. Alcohol, Other Drugs and Driving. It is categorized as a because of the effects it has on the.

8/26/2013 DMV UCSD CHP. Presenters. Law Enforcement s Identification and Referral of Medically Impaired Older Drivers. NHTSA Priority.

SPOTLIGHT ON MOVEMENT FUNCTION: COPING WITH ON/OFF PERIODS WELCOME AND INTRODUCTIONS

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by (Vale of York CCG/date)

Best Medical Treatments for Parkinson s disease

Diminished Driving Recognition and Screening of Older Drivers

Treatment of Parkinson s Disease: Present and Future

DriveWise Driving Evaluation. Ann M. Hollis OTR/L

Evaluating the Driving Ability in Patients with Parkinson s Disease Using a Driving Simulator

THE DANGERS OF DROWSY DRIVING. The Costs, Risks, and Prevention of Driver Fatigue

Emerging Technologies and Themes in Sleep Medicine. Luke Roling American Academy of Sleep Medicine, Communications Specialist; Darien, Illinois

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

P arkinson s disease (PD) is a progressive neurodegenerative

Stay Awake at The Wheel: Where Next?

Tools to Evaluate Cognitive Impairment

Sleep Apnea and Fatigue: Impact on Commercial Motor Vehicle Safety

Executive Summary. Parkinson s Disease, Multiple Sclerosis, and Commercial Motor Vehicle Driver Safety. September 2008

Dr Barry Snow. Neurologist Auckland District Health Board

Senior Drivers: The Clinician s Role in Maintaining Independence and Assessing Capabilities for Driving Safely.

Assessing cognition in ELDERLY drivers

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE

Let s Talk About drowsy Driving

The ABCs of BACs. I ve only had a few. I feel fine to drive. I m only going down the road. I ll take the back roads.

Identify the letter of the choice that best completes the statement or answers the question.

Parkinson s National Audit 2015

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

Florida as a Model State for Older Drivers. Kezia D. Awadzi, PhD March 7, 2008 CMS Annual Student Conference Gainesville, Florida

TO DRIVE OR NOT TO DRIVE: THAT IS THE QUESTION

Alberta Transportation. Driver Fitness and Monitoring

A Four Point Plan for Enhanced Support for Parkinson s Disease In B.C.

LONGITUDINAL ASSESSMENT OF OLDER DRIVERS IN A DMV SETTING

Evaluation of Parkinson s Patients and Primary Care Providers

Predicting Older Drivers' Difficulties Using the Roadwise Review

Parkinson s for Care Staff

National Blueprint for Injury Prevention in Older Drivers

Ratified by: Care and Clinical Policies Date: 17 th February 2016

Undiagnosed ADHD Among Unionized Drivers in Ghana: Public Health and Policy Implications

Non-Motor Symptoms of Parkinson s Disease

March 4, 2013 MEDIA ADVISORY. CONTACT: Tonya Mathis, Healing Field Coordinator, BACODA,

ARE YOUR LEVODOPA PILLS WORKING LIKE THEY USED TO?

THE SPATIAL EXTENT OF ATTENTION DURING DRIVING

Driving and Dementia Practical Tips for the Family Physician

Surgical Treatment: Patient Edition

Faculty. Joseph Friedman, MD

OPTIC FLOW IN DRIVING SIMULATORS

The PD You Don t See: Cognitive and Non-motor Symptoms

Can Tango Help Improve Quality of Life for Patients with Parkinson s Disease?

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

Cognitive-Motor Interference in Persons with Parkinson Disease

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Screening Drivers for Cognitive Impairment

10th Medicine Review Course st July Prakash Kumar

Driving and Dementia. By Alison Morris OT.

Welcome and Introductions

Note: This is an outcome measure and will be calculated solely using registry data.

Exploring the Needs of Aging Drivers in the Transportation System

In recent years, there has been increasing awareness

Welcome and Introductions

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Parkinson's Disease KP Update

DBS Programming. Paul S Fishman MD, PhD University of Maryland School of Medicine PFNCA 3/24/18

Prevalence of Drowsy-Driving Crashes: Estimates from a Large-Scale Naturalistic Driving Study

Note: This is an outcome measure and will be calculated solely using registry data.

Ontario s 80 and Over Licence Renewal Program: Measuring Safety Impact

Older Driver at Risk: What do I do?

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Enhanced Primary Care Pathway: Parkinson s Disease

Why is Grandma Asking for Directions to the Local Store? Assessing Older Driver Cognition and Safety

Parkinson s Founda.on

Dr Georgina Train Consultant Psychiatrist EMDASS service and Continuing Care.

The Pathway from Driver to Passenger: Strategies &Interventions for Enhancing Community Mobility

Transcription:

Driving with Parkinson s Disease Gina C. Pervall, MD Chief, Medical Advisory Board MDOT MVA PFNCA - March 2018

Disclosure I have no financial interest or affiliation with any entity producing, marketing, re-selling or distributing healthcare goods or services consumed by, or used on patients.

Objectives Identify at-risk drivers with Parkinson s Disease Understand MVA s review process for medically at-risk drivers Understand recommendations for driving Resources

Maryland Drivers Maryland has more than 4.3 million licensed drivers Largest group of licensed drivers is 50 59 years old More than 17% of Maryland drivers are 65 years & older

Medically Fit Driver A safe driver has the ability reason, remember, and react quickly to any driving hazard, or to avoid a collision.

Warning Signs of Unfit Driver Getting lost Not observant Accidents/Near misses Drifting across lanes Slow to make decisions Poor distance judging Driving too fast/slow Parking difficulties

Medical Risk Factors Physical/Functional Limitations Mental/Cognitive Limitations Visual Impairments Impairing Medications

PD & Driving Disruptions Physical Impairments Bradykinesia (slow movements) Rigid movements Tremor Poor coordination Decreased reaction time Reduced accuracy

PD & Driving Disruptions Cognitive Impairments Difficulty in making decisions Inability to think clearly Lack of concentration Dementia

PD & Driving Disruptions Visual Impairments Decreased contrast sensitivity Inability to distinguish between objects and their background Affects vision in low light (nighttime and glare)

PD & Driving Disruptions Medications Levodopa Motor fluctuations ( on and off periods) Dyskinesia (40%) Dopamine agonists Daytime sleepiness (22%) Sleep attacks (30%)

Driving Errors with PD Poor lane control/lane changing Driving at inappropriate speeds Late braking Poor negotiation of intersections Poor parking in reverse

PD & Predictors of Increased Crash Risk Duration/Stage of disease Older age Slowed brake reaction time Cognitive impairment

Parkinson s Disease and Driving Ability Singh, et al. 2006 154 individuals with PD Stage 1 59, Stage 2 55, Stage 3 40 Percent suitable to drive with PD ONLY Stage 1 100%; Stage 2 86%; Stage 3 33% Percent suitable to drive with PD and another medical condition Stage 1 93%; Stage 2 56%; Stage 3 0%

OT/Driver Rehab Assessment MVA Medical Review Multidisciplinary Approach Nurse Case Manager Medical Advisory Board Physician s Reports MVA Testing

MVA Functional Capacity Test Rapid walk - lower limb mobility Useful Field of View (UFOV ) - divided attention Delayed Recall - memory Motor Free Visual Perception Test (MVPT) - spatial relationships Trails B - visual search and sequencing, information processing speed, attention switching

Useful Field of View (UFOV ) 17

Motor Free Visual Perception Test

Motor Free Visual Perception Test

Trails B

OT/Driver Rehab Assessments Clinical Evaluation Medical History Physical Functioning Cognitive Functioning Behind-the-Wheel Evaluation Objective Clarification Immediate Feedback Guidance

FCT Results No Deficit No further testing/mva Drive Test Mild Deficit MVA Drive Test Moderate - Severe Deficit OT/Driver Rehab

OT/Driver Rehab Report No Deficits Driving Deficits with Potential to Compensate Retraining Vehicle modification Geographical restriction Daylight only driving Retire

Medical Advisory Board (MAB) Review Medical Information Physician report, LOC affidavit, treatment report, etc. MVA Screening/ Testing Functional Capacity Test (FCT), Vision, Law, Drive Test Referral Reports OT/Driver Rehab Assessment

MAB Recommendation Qualified to Drive WITHOUT Stipulations Approved for driving and case closed. Qualified to Drive WITH Stipulations Approved with restrictions, adaptive equipment, periodic monitoring. Not Qualified to Drive Temporary/permanent suspension of driver s license.

Resources Driver Assessments: at Home, the MVA, & by Professionals http://www.mva.maryland.gov/safety/older/driver-self-assessment-tools.htm Functional Capacity Test Screening http://www.mva.maryland.gov/safety/older/fct-screening.htm Maryland Access Point http://aging.maryland.gov/accesspoint/pages/default.aspx Safety for Older & Medically At-Risk Drivers http://www.mva.maryland.gov/safety/older/older-driver-safety-safe-mobility.htm